Recently Viewed
Clear All
Bidding Date
30-Jul-2024 to
01-Aug-2024
Issue Size
₹1856.74 Cr
Price Band
₹646 to ₹679
Allotment date
02-Aug-2024
Listing date
06-Aug-2024
Lot size
22
No. of shares
2,73,45,163
Fresh issue/OFS
₹680 Cr/₹1176.74 Cr
Established in 2004, Akums Drugs And Pharmaceuticals Ltd is a leading pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services both in India and overseas. Their core business focuses on CDMO services, which include Product Development and Manufacturing, Branded and Generic Formulations and Active Pharmaceutical Ingredients (APIs). They operate 10 manufacturing units with a total formulation manufacturing capacity of 49.23 billion units annually as of March 31, 2024. Their key clients include Alembic Pharmaceuticals, Alkem Laboratories, Blue Cross Laboratories, Cipla, Dabur India, Dr. Reddy’s Laboratories, Mankind Pharma, MedPlus Health Services, Natco Pharma, and Sun Pharmaceutical Industries.
Read our in-depth analysis of the Akums Drugs And Pharmaceuticals Ltd IPO Here 
Category
Status
QIBs
90.1x
NIIs
42.1x
Retail
20.5x
Others
4.1x
Total
63.4x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Sai Parenteral’s | 372 - 392 | 24-Mar-2026 to 27-Mar-2026 |
| Powerica | 375 - 395 | 24-Mar-2026 to 27-Mar-2026 |
| TIPCO Engineering India | 84 - 89 | 23-Mar-2026 to 25-Mar-2026 |
The issue size of Akums Drugs And Pharmaceuticals is ₹1,856.74 Cr.
Akums Drugs And Pharmaceuticals falls into Pharmaceuticals industry.
The Akums Drugs And Pharmaceuticals IPO will be listed on BSE.
The open and close dates for the Akums Drugs And Pharmaceuticals are 30-Jul-2024 & 01-Aug-2024.
The price band for the Akums Drugs And Pharmaceuticals ipo is ₹646 to ₹679
The listing date of Akums Drugs And Pharmaceuticals IPO is 06-Aug-2024.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Akums Drugs And Pharmaceuticals total subscription ratio is 63.4X.
Key financial of the Akums Drugs And Pharmaceuticals are:
| Akums Drugs And Pharmaceuticals | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 4178.18 | 3654.82 | 3671.89 |
| EBIT (₹ Cr) | -2.66 | 181.17 | -186.4 |
| Proft after Tax (₹ Cr) | 0.79 | 97.82 | -250.87 |
| Debt (₹ Cr) | 491.56 | 536.97 | 357.95 |
| Net Worth (₹ Cr) | 720.49 | 723.37 | 625.17 |
| RoE (%) | 0.11 | 13.52 | -40.13 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
